MP69-15 UPREGULATION OF CDK1 AND TOP2A IS ASSOCIATED WITH POOR PROGNOSIS IN ADRENOCORTICAL CARCINOMA

Hengchuan Su,Dingwei Ye
DOI: https://doi.org/10.1097/01.ju.0000557048.24240.bb
2019-01-01
Abstract:You have accessJournal of UrologyAdrenal (MP69)1 Apr 2019MP69-15 UPREGULATION OF CDK1 AND TOP2A IS ASSOCIATED WITH POOR PROGNOSIS IN ADRENOCORTICAL CARCINOMA Hengchuan Su* and Dingwei Ye Hengchuan Su*Hengchuan Su* More articles by this author and Dingwei YeDingwei Ye More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000557048.24240.bbAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: In order to identify potential novel biomarkers of adrenocortical carcinoma (ACC), we re-evaluated published message RNA (mRNA) expression profiling data. METHODS: The mRNA expression profiles in ACC microarray dataset GSE33371were analyzed and an independent cohort of 44 clinical samples including 20 ACC and 24adrenocortical adenoma (ACA) patients were used to confirm the most statistically significant mRNAs which were related with poor prognosis of these patients by real time PCR. Next, the relationships between the selected mRNAs and ACC patients’ clinicopathological features and prognosis were investigated. RESULTS: The PCR results in a cohort of 20 ACC and 24 ACA tissues were used for confirmation of the selected three mRNAs (CDK1, ŒRRM2 and TOP2A). The PCR results showed that the expression of two mRNA (CDK1 and TOP2A) were significantly upregulated in ACC. Kaplan–Meier analysis and univariate Cox regression indicated these two mRNA had significant hazard ratios for predicting clinical outcome. Spearman analysis showed that CDK1 expression was significantly correlated with TOP2A in our tissue. Based on the expression of these mRNA in our tissue, we established a set of two mRNAs signature that could also correlate with OS significantly in our tissues and GSE33371 test series. CONCLUSIONS: mRNAs are involved in ACC carcinogenesis. Increased CDK1 and TOP2A expression and these two mRNAs signature may be adverse prognostic factors in ACC patients. Source of Funding: none Shanghai, China, People’s Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e990-e990 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Hengchuan Su* More articles by this author Dingwei Ye More articles by this author Expand All Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?